Daniel Stauder
Stock Analyst at JMP Securities
(1.75)
# 2,694
Out of 4,829 analysts
17
Total ratings
45.45%
Success rate
-3.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Reiterates: Market Outperform | $33 | $28.77 | +14.70% | 4 | May 6, 2025 | |
| ATRC AtriCure | Reiterates: Market Outperform | $60 | $31.81 | +88.62% | 6 | Apr 30, 2025 | |
| STIM Neuronetics | Maintains: Market Outperform | $3 → $7 | $4.14 | +69.08% | 1 | Mar 5, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $82.46 | +33.40% | 4 | Feb 28, 2025 | |
| AXON Axon Enterprise | Reiterates: Market Outperform | $725 | $693.10 | +4.60% | 1 | Feb 26, 2025 | |
| AVNS Avanos Medical | Reiterates: Market Perform | n/a | $13.10 | - | 1 | May 7, 2024 |
Artivion
May 6, 2025
Reiterates: Market Outperform
Price Target: $33
Current: $28.77
Upside: +14.70%
AtriCure
Apr 30, 2025
Reiterates: Market Outperform
Price Target: $60
Current: $31.81
Upside: +88.62%
Neuronetics
Mar 5, 2025
Maintains: Market Outperform
Price Target: $3 → $7
Current: $4.14
Upside: +69.08%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $82.46
Upside: +33.40%
Axon Enterprise
Feb 26, 2025
Reiterates: Market Outperform
Price Target: $725
Current: $693.10
Upside: +4.60%
Avanos Medical
May 7, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $13.10
Upside: -